| Ytd | 32.07% | |
| 1y | 57.37% |
| Open | 104.58 | Prev Close | 104.81 | Low | 104.24 | High | 105.04 | Mkt Cap | 133.77B |
| Vol | 542.87K | Avg Vol | 8.38M | EPS | 2.28 | P/E | 45.98 | Forward P/E | 12.50 |
| Beta | 0.62 | Short Ratio | 2.87 | Inst. Own | 90.28% | Dividend | 2.66 | Div Yield | 2.57 |
| Ex Div Date | 04-23 | Earning | 07-30 | 50-d Avg | 92.87 | 200-d Avg | 81.42 | 1yr Est | 105.69 |
Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combi
@Theotrade 's Don Kaufman takes us through today's Big 3 and offers example trades for his picks. He
This relationship between inflation and value stocks' outperformance is often overlooked. Many inves
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take
Joel Greenblatt's Magic Formula, popularized in The Little Book That Beats the Market, ranks stocks
CVS Health announced a program to help patients get easier access to GLP-1 medicines. This initiativ
Local organizations receive Hometown Fund support to expand access to health care, food, housing and
Local organizations receive Hometown Fund support to expand access to health care, food, housing and
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
B of A Securities analyst Allen Lutz maintains CVS Health (NYSE:CVS) with a Buy and raises the pr
On June 22, 2026, CVS Health Corp (CVS) shares rose 3.0% to a current price of $101.30. The stock ha
Novo-Nordisk shares are trading higher by more than 6% on Monday as GLP‑1 support initiatives aimed
It is to start participating in a Medicare discount program for such medications, among other measur
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
As demand for GLP-1 medications continues to increase across the U.S., CVS Health® (NYSE:CVS) today
New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-c
Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find o
Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to
CVS Health's financial results are improving due to several initiatives. These efforts could continu
Earlier this month, Mizuho's Ann Hynes raised her price target to $115 per share. Following the late
STNE, USNA, STRA, NEXA and CVS passed a low price-to-book screen, combining discounted valuations wi
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take
Federal investigators found Medicare Advantage plans frequently denied requests for nursing and reha
Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price t
Morgan Stanley names UnitedHealth its top managed care pick, citing AI-driven growth, efficiency gai
Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises t
The battle between Amazon.com and Walmart has produced a new leader for the Fortune 500 list for 202
Truist Securities analyst David Macdonald maintains CVS Health (NYSE:CVS) with a Buy and raises t
Eli Lilly (NYSE:LLY) shares jumped on Thursday morning after securing expanded PBM coverage for its
This expanded use of Agentforce Health, Salesforce's industry vertical solution for health care
These changes build on Caremark's industry leading efforts as a pharmacy benefits manager to exp
Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price t
Major M&A deals this week include: LVMH agrees to sell Marc Jacobs to WHP Global, 365 Markets bu
Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises t
Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE: CVS),
Bernstein analyst Lance Wilkes maintains CVS Health (NYSE:CVS) with a Outperform and raises the p
JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and raises the pric
https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-warns-cvs-potential-m
TD Cowen analyst Charles Rhyee maintains CVS Health (NYSE:CVS) with a Buy and raises the price ta
NVIDIA and CVS Health named as top final trades by industry experts, while Transocean and Vertiv Hol
Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and raises t
UBS analyst Kevin Caliendo maintains CVS Health (NYSE:CVS) with a Buy and raises the price target
CVS Health (NYSE:CVS) reported upbeat Q1 earnings & raised 2026 guidance. Analysts have positive
RBC Capital analyst Ben Hendrix maintains CVS Health (NYSE:CVS) with a Outperform and raises the
Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and raises the pric
Truist Securities analyst David Macdonald maintains CVS Health (NYSE:CVS) with a Buy and raises t
Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health (NYSE:CVS) with a Outperform a